+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Denosumab (Prolia & Xgeva) Biosimilars Pipeline Review - Product Thumbnail Image

Denosumab (Prolia & Xgeva) Biosimilars Pipeline Review

  • Report
  • May 2025
  • Global
From
Aflibercept (Eylea) Biosimilars Pipeline Review - Product Thumbnail Image

Aflibercept (Eylea) Biosimilars Pipeline Review

  • Report
  • May 2025
  • Global
From
Claudin 18.2-Targeted Immunotherapy: A Landscape Analysis of Stakeholders, Drug Modalities, Pipeline and Business Opportunities from An Industry Perspective - Product Thumbnail Image

Claudin 18.2-Targeted Immunotherapy: A Landscape Analysis of Stakeholders, Drug Modalities, Pipeline and Business Opportunities from An Industry Perspective

  • Report
  • August 2023
  • 267 Pages
  • Global
From
GPRC5D-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis - Product Thumbnail Image

GPRC5D-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis

  • Report
  • July 2022
  • 60 Pages
  • Global
From
ROR1-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis - Product Thumbnail Image

ROR1-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis

  • Report
  • June 2022
  • 115 Pages
  • Global
From
Cadherin 17: A Target Opportunity To Develop Effector-Enhanced Drug Modalities - Product Thumbnail Image

Cadherin 17: A Target Opportunity To Develop Effector-Enhanced Drug Modalities

  • Report
  • May 2022
  • 32 Pages
  • Global
From
Claudin 6: A Target Opportunity To Develop Effector-Enhanced Drug Modalities - Product Thumbnail Image

Claudin 6: A Target Opportunity To Develop Effector-Enhanced Drug Modalities

  • Report
  • May 2022
  • 50 Pages
  • Global
From
Precision Cancer Therapeutics, 2022 - Product Thumbnail Image

Precision Cancer Therapeutics, 2022

  • Report
  • November 2022
  • 154 Pages
  • Global
From
CAR-T Cell Therapy Market Review - Product Thumbnail Image

CAR-T Cell Therapy Market Review

  • Report
  • December 2019
  • 59 Pages
  • Global
From
Antibody Drug Conjugates (ADC) Market by Product (Kadcyla, Enhertu, Padcev, Polivy), Linker Type (Cleavable, Non-Cleavable), Payload Type (Calicheamicin, MMAE), Target (HER2, CD30, CD22), Disease, and Region - Forecast to 2028 - Product Thumbnail Image

Antibody Drug Conjugates (ADC) Market by Product (Kadcyla, Enhertu, Padcev, Polivy), Linker Type (Cleavable, Non-Cleavable), Payload Type (Calicheamicin, MMAE), Target (HER2, CD30, CD22), Disease, and Region - Forecast to 2028

  • Report
  • October 2023
  • 273 Pages
  • Global
From
Prostate Health Market by Disease Indication (Prostate Cancer, PARP Inhibitors, Cytotoxic Drug, Benign Prostate Hyperplasia (BPH), Tamsulosin, 5 Alpha Reductase, Prostatitis, OTC, Prescription (Rx), & Region (NA, Europe, APAC) - Global Forecasts to 2026 - Product Thumbnail Image

Prostate Health Market by Disease Indication (Prostate Cancer, PARP Inhibitors, Cytotoxic Drug, Benign Prostate Hyperplasia (BPH), Tamsulosin, 5 Alpha Reductase, Prostatitis, OTC, Prescription (Rx), & Region (NA, Europe, APAC) - Global Forecasts to 2026

  • Report
  • December 2021
  • 95 Pages
  • Global
From
Leukemia Therapeutics Market by Type (CLL, ALL, CML, AML), Treatment Type (Chemotherapy & Targeted Drugs), Mode of Administration (Oral, Injectable), Molecule Type (Small Molecules, Biologics), Gender, and Region - Global Forecast to 2024 - Product Thumbnail Image

Leukemia Therapeutics Market by Type (CLL, ALL, CML, AML), Treatment Type (Chemotherapy & Targeted Drugs), Mode of Administration (Oral, Injectable), Molecule Type (Small Molecules, Biologics), Gender, and Region - Global Forecast to 2024

  • Report
  • May 2019
  • 126 Pages
  • Global
From
Global Claudin 18.2 Targeted Therapy Market Opportunity & Clinical Trials Insight 2028 - Product Thumbnail Image

Global Claudin 18.2 Targeted Therapy Market Opportunity & Clinical Trials Insight 2028

  • Report
  • December 2023
  • 220 Pages
  • Global
From
Global Tumor Infiltrating Lymphocytes Therapy Market Opportunity & Clinical Trials Insight 2028 - Product Thumbnail Image

Global Tumor Infiltrating Lymphocytes Therapy Market Opportunity & Clinical Trials Insight 2028

  • Report
  • March 2023
  • 300 Pages
  • Global
From
China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028 - Product Thumbnail Image

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

  • Report
  • September 2022
  • 300 Pages
  • China
From
Global Combination Cancer Immunotherapy Market Opportunity and Clinical Trials Insight 2028 - Product Thumbnail Image

Global Combination Cancer Immunotherapy Market Opportunity and Clinical Trials Insight 2028

  • Report
  • June 2022
  • 1500 Pages
  • Global
From
Global Leukemia Antibodies Market, Drug Sales & Clinical Trials Insight 2028 - Product Thumbnail Image

Global Leukemia Antibodies Market, Drug Sales & Clinical Trials Insight 2028

  • Report
  • May 2022
  • 330 Pages
  • Global
From
Global Immune Checkpoint Inhibitors Biomarkers & Clinical Trials Insight 2028 - Product Thumbnail Image

Global Immune Checkpoint Inhibitors Biomarkers & Clinical Trials Insight 2028

  • Drug Pipelines
  • March 2022
  • 900 Pages
  • Global
From
Global B Cell Maturation Antigen (BCMA) Targeted Therapy Market & Clinical Trials Insight 2026 - Product Thumbnail Image

Global B Cell Maturation Antigen (BCMA) Targeted Therapy Market & Clinical Trials Insight 2026

  • Report
  • November 2021
  • 222 Pages
  • Global
From
Global EZH2 Inhibitor Market Opportunity, Sales & Clinical Trials Insight 2026 - Product Thumbnail Image

Global EZH2 Inhibitor Market Opportunity, Sales & Clinical Trials Insight 2026

  • Report
  • August 2021
  • 105 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more